Drug repositioning is an alternative for the treatment of coronavirus COVID-19

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorSerafin, Marissa B.-
Autor(es): dc.creatorBottega, Angelita-
Autor(es): dc.creatorFoletto, Vitória S.-
Autor(es): dc.creatorRosa, Taciéli F. da-
Autor(es): dc.creatorHörner, Andreas-
Autor(es): dc.creatorHörner, Rosmari-
Data de aceite: dc.date.accessioned2026-02-09T11:33:31Z-
Data de disponibilização: dc.date.available2026-02-09T11:33:31Z-
Data de envio: dc.date.issued2020-06-23-
Data de envio: dc.date.issued2020-06-23-
Data de envio: dc.date.issued2020-06-
Fonte completa do material: dc.identifierhttps://repositorio.ufla.br/handle/1/41546-
Fonte completa do material: dc.identifierhttps://www.sciencedirect.com/science/article/pii/S0924857920301266-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/1142338-
Descrição: dc.descriptionGiven the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-CoV, with the potential for use in the treatment of COVID-19 disease.-
Idioma: dc.languageen-
Publicador: dc.publisherElsevier-
Direitos: dc.rightsrestrictAccess-
???dc.source???: dc.sourceInternational Journal of Antimicrobial Agents-
Palavras-chave: dc.subjectCOVID-19-
Palavras-chave: dc.subjectSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-
Título: dc.titleDrug repositioning is an alternative for the treatment of coronavirus COVID-19-
Tipo de arquivo: dc.typeArtigo-
Aparece nas coleções:Repositório Institucional da Universidade Federal de Lavras (RIUFLA)

Não existem arquivos associados a este item.